Stoke Therapeutics, Inc. (STOK)
32.77
+0.78
(+2.44%)
USD |
NASDAQ |
Feb 10, 15:49
Stoke Therapeutics Market Cap : 1.872B for Feb. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 27.77B |
| Insmed, Inc. | 31.73B |
| Pfizer Inc. | 157.38B |
| Mirum Pharmaceuticals, Inc. | 5.186B |
| Moderna, Inc. | 16.41B |
Market Cap Related Metrics
| PE Ratio | 49.66 |
| PS Ratio | 9.299 |
| Price to Book Value | 6.075 |
| Price to Free Cash Flow | 36.51 |
| Price | 32.77 |
| Earnings Yield | 2.01% |
| Operating PE Ratio | 70.31 |
| Normalized PE Ratio | 49.66 |